Wijkhuijs AJ - Search Results

1

Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques.

Verhagen OJ, Wijkhuijs AJ, van der Sluijs-Gelling AJ, Szczepański T, van der Linden-Schrever BE, Pongers-Willemse MJ, van Wering ER, van Dongen JJ, van der Schoot CE. Verhagen OJ, et al. Among authors: wijkhuijs aj. Leukemia. 1999 Aug;13(8):1298-9. doi: 10.1038/sj.leu.2401451. Leukemia. 1999. PMID: 10450765 No abstract available.

2

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.

Pongers-Willemse MJ, Verhagen OJ, Tibbe GJ, Wijkhuijs AJ, de Haas V, Roovers E, van der Schoot CE, van Dongen JJ. Pongers-Willemse MJ, et al. Among authors: wijkhuijs aj. Leukemia. 1998 Dec;12(12):2006-14. doi: 10.1038/sj.leu.2401246. Leukemia. 1998. PMID: 9844931

3

Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease.

Szczepański T, Beishuizen A, Pongers-Willemse MJ, Hählen K, Van Wering ER, Wijkhuijs AJ, Tibbe GJ, De Bruijn MA, Van Dongen JJ. Szczepański T, et al. Among authors: wijkhuijs aj. Leukemia. 1999 Feb;13(2):196-205. doi: 10.1038/sj.leu.2401277. Leukemia. 1999. PMID: 10025893 Clinical Trial.

4

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia.

Verhagen OJ, Willemse MJ, Breunis WB, Wijkhuijs AJ, Jacobs DC, Joosten SA, van Wering ER, van Dongen JJ, van der Schoot CE. Verhagen OJ, et al. Among authors: wijkhuijs aj. Leukemia. 2000 Aug;14(8):1426-35. doi: 10.1038/sj.leu.2401801. Leukemia. 2000. PMID: 10942239

5

Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.

van der Velden VH, Jacobs DC, Wijkhuijs AJ, Comans-Bitter WM, Willemse MJ, Hählen K, Kamps WA, van Wering ER, van Dongen JJ. van der Velden VH, et al. Among authors: wijkhuijs aj. Leukemia. 2002 Aug;16(8):1432-6. doi: 10.1038/sj.leu.2402636. Leukemia. 2002. PMID: 12145681

6

Inhibition affecting RQ-PCR-based assessment of minimal residual disease in acute lymphoblastic leukemia: reversal by addition of bovine serum albumin.

Moppett J, van der Velden VH, Wijkhuijs AJ, Hancock J, van Dongen JJ, Goulden N. Moppett J, et al. Among authors: wijkhuijs aj. Leukemia. 2003 Jan;17(1):268-70. doi: 10.1038/sj.leu.2402751. Leukemia. 2003. PMID: 12529693 No abstract available.

7

Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation.

Lankester AC, Bierings MB, van Wering ER, Wijkhuijs AJ, de Weger RA, Wijnen JT, Vossen JM, Versluys B, Egeler RM, van Tol MJ, Putter H, Révész T, van Dongen JJ, van der Velden VH, Schilham MW. Lankester AC, et al. Among authors: wijkhuijs aj. Leukemia. 2010 Aug;24(8):1462-9. doi: 10.1038/leu.2010.133. Epub 2010 Jun 10. Leukemia. 2010. PMID: 20535148

8

Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia.

Brüggemann M, van der Velden VH, Raff T, Droese J, Ritgen M, Pott C, Wijkhuijs AJ, Gökbuget N, Hoelzer D, van Wering ER, van Dongen JJ, Kneba M. Brüggemann M, et al. Among authors: wijkhuijs aj. Leukemia. 2004 Apr;18(4):709-19. doi: 10.1038/sj.leu.2403263. Leukemia. 2004. PMID: 14961040

9

Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage.

Szczepański T, Pongers-Willemse MJ, Langerak AW, Harts WA, Wijkhuijs AJ, van Wering ER, van Dongen JJ. Szczepański T, et al. Among authors: wijkhuijs aj. Blood. 1999 Jun 15;93(12):4079-85. Blood. 1999. PMID: 10361104 Free article.

10

TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.

Weigelt K, Carvalho LA, Drexhage RC, Wijkhuijs A, de Wit H, van Beveren NJ, Birkenhäger TK, Bergink V, Drexhage HA. Weigelt K, et al. Brain Behav Immun. 2011 Aug;25(6):1162-9. doi: 10.1016/j.bbi.2011.03.006. Epub 2011 Mar 21. Brain Behav Immun. 2011. PMID: 21421043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page